SCHEMBL6985385

SCHEMBL6985385

CCCCOc1ccc([S+]([O-])N2CC(NCC(O)COc3ccc(OS(=O)(=O)c4ccc(OCCCC)cc4)cc3)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 7/20 0.47
ADRB1 P08588 5/20 0.47
ADRB2 P07550 3/20 0.47
MMP1 P03956 6/20 0.41
MMP3 P08254 6/20 0.41
MMP7 P09237 5/20 0.41
MMP13 P45452 5/20 0.41
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
CA4 P22748 1/20 0.39
CA7 P43166 1/20 0.39
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
CA12 O43570 2/20 0.38
MMP2 P08253 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984819 0.85 ADRB3 (0.65) ADRB3ADRB1ADRB2MMP1MMP3
SCHEMBL6985800 0.76 ADRB3 (0.79) ADRB3ADRB1ADRB2MMP1MMP3
SCHEMBL6985805 0.76 ADRB3 (0.79) ADRB3ADRB1ADRB2MMP1MMP3
SCHEMBL6987545 0.72 HRH3 (0.43) ADRB3ADRB1ADRB2LMNAMEN1
SCHEMBL6982931 0.70 ADRB3 (0.82) ADRB3ADRB1ADRB2CA1CA2
SCHEMBL6074513 0.70 ADRB1 (0.54) ADRB3ADRB1ADRB2MEN1MAPT
SCHEMBL6988523 0.67 ADRB3 (0.67) ADRB3ADRB1ADRB2CA1CA2
SCHEMBL6982731 0.66 ADRB3 (0.43) ADRB3ADRB1ADRB2MMP1MMP3
SCHEMBL6074347 0.66 ADRB3 (0.52) ADRB3ADRB1ADRB2CA1CA2
SCHEMBL22187399 0.64 CA12 (0.74) MMP1MMP13CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1328512-A2 CYCLYLAMINE SULFONAMIDES AS BETA-3 ADRENERGIC RECEPTOR AGONISTS Wyeth (US) 2003-07-23 EP disclosed
WO-2002006221-A2 CYCLYLAMINE SULFONAMIDES AS BETA-3 ADRENERGIC RECEPTOR AGONISTS WYETH (US) 2002-01-24 WO disclosed